Contact this trialFirst, we need to learn more about you.
Virus Therapy
Long-term Follow-up with Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy
Recruiting4 awardsPhase 3
Richmond, Virginia
This trial is for people with Spinal Muscular Atrophy who have been treated with onasemnogene abeparvovec-xioi in the past. Researchers will monitor safety and efficacy of the treatment long-term.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service